The Clorox Company
CLX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,429,000 | $1,988,000 | $1,668,000 | $1,686,000 |
| % Growth | -28.1% | 19.2% | -1.1% | – |
| Cost of Goods Sold | $835,000 | $1,067,000 | $929,000 | $951,000 |
| Gross Profit | $594,000 | $921,000 | $739,000 | $735,000 |
| % Margin | 41.6% | 46.3% | 44.3% | 43.6% |
| R&D Expenses | $28,000 | $32,000 | $27,000 | $31,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $443,000 | $467,000 | $474,000 | $471,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $471,000 | $499,000 | $501,000 | $502,000 |
| Operating Income | $123,000 | $422,000 | $238,000 | $233,000 |
| % Margin | 8.6% | 21.2% | 14.3% | 13.8% |
| Other Income/Exp. Net | -$16,000 | -$12,000 | $16,000 | $4,000 |
| Pre-Tax Income | $107,000 | $410,000 | $254,000 | $237,000 |
| Tax Expense | $25,000 | $74,000 | $63,000 | $43,000 |
| Net Income | $80,000 | $332,000 | $186,000 | $193,000 |
| % Margin | 5.6% | 16.7% | 11.2% | 11.4% |
| EPS | 0.65 | 2.7 | 1.51 | 1.56 |
| % Growth | -75.9% | 78.8% | -3.2% | – |
| EPS Diluted | 0.65 | 2.68 | 1.5 | 1.54 |
| Weighted Avg Shares Out | 122,629 | 123,173 | 123,367 | 123,766 |
| Weighted Avg Shares Out Dil | 123,018 | 123,744 | 124,066 | 124,662 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,000 | $2,000 | $2,000 | $2,000 |
| Interest Expense | $26,000 | $25,000 | $27,000 | $25,000 |
| Depreciation & Amortization | $56,000 | $57,000 | $55,000 | $53,000 |
| EBITDA | $189,000 | $492,000 | $336,000 | $315,000 |
| % Margin | 13.2% | 24.7% | 20.1% | 18.7% |